REMAX
Price
$20.64
Change
-$0.17 (-0.82%)
Updated
Oct 7 closing price
Net Assets
835.45M
RNWAX
Price
$91.07
Change
-$0.30 (-0.33%)
Updated
Oct 7 closing price
Net Assets
75.16B
Interact to see
Advertisement

REMAX vs RNWAX

Header iconREMAX vs RNWAX Comparison
Open Charts REMAX vs RNWAXBanner chart's image
Russell Inv Emerging Markets A
Price$20.64
Change-$0.17 (-0.82%)
VolumeN/A
Net Assets835.45M
American Funds New World R1
Price$91.07
Change-$0.30 (-0.33%)
VolumeN/A
Net Assets75.16B
REMAX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
REMAX vs. RNWAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMAX is a Hold and RNWAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 75.2B vs. REMAX (835M). REMAX pays higher dividends than RNWAX: REMAX (1.83) vs RNWAX (0.00). REMAX was incepted earlier than RNWAX: REMAX (19 years) vs RNWAX (23 years). RNWAX (1.66) is less costly to investors than REMAX (1.56). REMAX is a more actively managed with annual turnover of: 66.00 vs. RNWAX (37.00). REMAX has a lower initial minimum investment than RNWAX: REMAX (0) vs RNWAX (250). REMAX annual gain was more profitable for investors over the last year : 19.73 vs. RNWAX (11.50). RNWAX return over 5 years is better than : 25.36 vs. REMAX (20.07).
REMAXRNWAXREMAX / RNWAX
Total Expense Ratio1.441.6687%
Annual Report Gross Expense Ratio1.561.6694%
Fund Existence19 years23 years-
Gain YTD31.62623.686134%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets835M75.2B1%
Annual Yield % from dividends1.830.00-
Returns for 1 year19.7311.50172%
Returns for 3 years61.9454.36114%
Returns for 5 years20.0725.3679%
Returns for 10 years48.4986.1156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGX2.950.26
+9.67%
Metagenomi
MLTX9.280.62
+7.16%
MoonLake Immunotherapeutics
HCWB4.03N/A
N/A
HCW Biologics Inc
ACMR40.46-1.32
-3.16%
ACM Research
WSO396.34-13.65
-3.33%
Watsco